p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas
p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas
复制标题
DOI:
10.1016/j.ygyno.2004.07.026
复制
发表时间:
2004-10-01
影响因子:
4.7
通讯作者:
Holm, R
中科院分区:
文献类型:
--
作者:
Knopp, S;Bjorge, T;Holm, R
Objective. Aberrant expression of the cell cycle kinase inhibitors p 16, p21, and p27 has been associated with poor prognosis in a variety of human malignancies. Little is known, however, about their clinical impact in vulvar carcinoma patients. Thus, we analyzed a larger series of vulvar squamous cell carcinomas and compared the results with clinical outcome.Methods. A total of 224 vulvar squamous cell carcinomas were immunohistochemically investigated for expression of p 16, p21, and p27 using the biotin-streptavidin-peroxidase method and the OptiMax Plus automated cell staining system.Results. High p16 (greater than or equal to5%) positive nuclear immunostaining was found in 69 (31%) cases, high p21 (any staining) protein levels was detected in 95 (42%) cases, and low p27 (less than or equal to50% positive nuclei) staining was seen in 170 (76%) cases. High expression of p 16 was related to lower patient age and low expression of p53. High expression of p16 indicated abetter prognosis in the multivariate analysis (RR=0.5, 95% CI=0.2-1.0) and less risk of developing lymph node metastasis (OR=0.3, 95% CI=0.2-0.7). High level of p21 was significantly associated with shorter survival in patients staged FIGO I and II (RR=3.4, 95% CI=1.3-9.3). We found no significant correlation between the expression of p27 and any of the clinicopathological variables.Conclusions. Our study indicates a prognostic relevance for p 16 and p21 immunoreactivity. Low level of p 16 protein and high level of p21 protein were associated with a shorter disease-related survival. We did not find p27 protein expression to be useful as a prognostic indicator in vulvar carcinoma patients. (C) 2004 Elsevier Inc. All rights reserved.